Shanghai Micro-Chung Medical Robots (Group) Co., Ltd. (Micro-Chung Robots) announced that its independently developed Tomai® laparoscopic surgical robot system has been successfully certified in the EU CE for a wide range of surgical procedures, becoming the first domestic laparoscopic surgical robot to receive this certification. With its precise operation and high security, the Tomai robot system has completed nearly 3000 procedures in 90 medical institutions worldwide, including 200 5G remote surgeries. This certification lays the foundation for the commercialization and clinical application of Tomai in the European and global markets, marking a new era in the internationalization of the surgical robot industry in China. Shareholders and potential investors should act with caution. The announcement was made by Mr. Sun Hongbin, Chairman of the Board of Directors of the Company, on 9 May 2024.

Shanghai Micro-Chung Medical Robots (Group) Co., Ltd. (Micro-Chung Robots) announced that its independently developed Tomai® laparoscopic surgical robot system has been successfully certified in the EU CE for a wide range of surgical procedures, becoming the first domestic laparoscopic surgical robot to receive this certification. With its precise operation and high security, the Tomai robot system has completed nearly 3000 procedures in 90 medical institutions worldwide, including 200 5G remote surgeries. This certification lays the foundation for the commercialization and clinical application of Tomai in the European and global markets, marking a new era in the internationalization of the surgical robot industry in China. Shareholders and potential investors should act with caution. The announcement was made by Mr. Sun Hongbin, Chairman of the Board of Directors of the Company, on 9 May 2024.